(Q36314075)

13 August 2017

1 reference

title

PDE-5 inhibitors: current status and future trends (English)

1 reference

13 August 2017

Puneet Masson

1

1 reference

13 August 2017

Sarah M Lambert

series ordinal

2

1 reference

13 August 2017

Melissa Brown

series ordinal

3

1 reference

13 August 2017

Ridwan Shabsigh

series ordinal

4

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Urologic Clinics of North America

13 August 2017

published in

1 reference

13 August 2017

volume

32

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

511-25, viii

1 reference

Phosphodiesterases in the vascular system

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Molecular biology and pharmacology of PDE-5-inhibitor therapy for erectile dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Cardiovascular effects of sildenafil citrate and recommendations for its use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Erectile dysfunction and cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

IC351 (tadalafil, Cialis): update on clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Assessment of the efficacy and safety of Viagra (sildenafil citrate) in men with erectile dysfunction during long-term treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Oral drug therapy for erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Guidelines on erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

The real-life safety and efficacy of vardenafil: an international post-marketing surveillance study--results from 29 358 German patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Time course of the interaction between tadalafil and nitrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Prevalence of self-reported erectile dysfunction in people with long-term IDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Effects of tadalafil on erectile dysfunction in men with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Efficacy and safety of sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Sildenafil Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Role of Viagra after radical prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic Prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Intracavernosal injection in the treatment of impotence: a prospective study of sexual, psychological, and marital functioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

A psychological profile of the sexual dysfunctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

The effect of age, ethnicity and geographical location on impotence and quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

The clinical studies of sildenafil for the ageing male

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.08.012

10.1016/J.UCL.2005.08.012

7 January 2021

Identifiers

DOI

1 reference

13 August 2017

1 reference